基本信息
浏览量:5
职业迁徙
个人简介
Research Interests
Pathogenesis of systemic autoimmune diseases: My major research interests include the molecular understanding of systemic lupus erythematosus (SLE), rheumatoid arthritis, Sjogren’s syndrome, vasculitis, and other systemic autoimmune diseases. In particular, we aim to investigate the samples from the patients, coupled with the high-quality longitudinal clinical data from the patients. In 1990s, the peripheral blood from the patients with SLE were immunized to mice and generated a long list of monoclonal antibodies (mAbs) reacting with the patients’ peripheral lymphocytes. By screening with the increased expression of the molecules recognized by the mAbs in SLE patients, compared to healthy individual, we identified increased expression of alpha4beta1 (α4β1)integrin with vasculitis, increased alphaEbeta7(αEβ7) with epithelitis, and down-regulated TCR(CD3) zeta expression in SLE. More recently, we utilize, whole or cell-specific RNA expression with gene chip, single cell RNA sequencing, and CyTOF for the analysis on the peripheral blood, synovium, salivary glands, and kidney samples from the patients. For the analysis, I strongly try to obtain the combined data from the longitudinal sampling, depending on the appropriate timing on the treatment, and the high-quality standardized clinical data to provide high-quality and reproducible outp
Clinical research for systemic autoimmune diseases: I participated in a number of pharmaceutical company-sponsored, physician initiated clinical trials and clinical studies as a principal investigator or an investigator. Particularly, I played a lead investigator for the global phase 3 clinical trials for RA with anti-IL-6 mAbs and Jak inhibitors. By these intense experiences with clinical trials and studies, I was nominated as a committee member for European League Against Rheumatism (EULAR) recommendation for RA in 2016 and 2019 and would be joining the meeting for 2022 revision as only one member from Japan.
Pathogenesis of systemic autoimmune diseases: My major research interests include the molecular understanding of systemic lupus erythematosus (SLE), rheumatoid arthritis, Sjogren’s syndrome, vasculitis, and other systemic autoimmune diseases. In particular, we aim to investigate the samples from the patients, coupled with the high-quality longitudinal clinical data from the patients. In 1990s, the peripheral blood from the patients with SLE were immunized to mice and generated a long list of monoclonal antibodies (mAbs) reacting with the patients’ peripheral lymphocytes. By screening with the increased expression of the molecules recognized by the mAbs in SLE patients, compared to healthy individual, we identified increased expression of alpha4beta1 (α4β1)integrin with vasculitis, increased alphaEbeta7(αEβ7) with epithelitis, and down-regulated TCR(CD3) zeta expression in SLE. More recently, we utilize, whole or cell-specific RNA expression with gene chip, single cell RNA sequencing, and CyTOF for the analysis on the peripheral blood, synovium, salivary glands, and kidney samples from the patients. For the analysis, I strongly try to obtain the combined data from the longitudinal sampling, depending on the appropriate timing on the treatment, and the high-quality standardized clinical data to provide high-quality and reproducible outp
Clinical research for systemic autoimmune diseases: I participated in a number of pharmaceutical company-sponsored, physician initiated clinical trials and clinical studies as a principal investigator or an investigator. Particularly, I played a lead investigator for the global phase 3 clinical trials for RA with anti-IL-6 mAbs and Jak inhibitors. By these intense experiences with clinical trials and studies, I was nominated as a committee member for European League Against Rheumatism (EULAR) recommendation for RA in 2016 and 2019 and would be joining the meeting for 2022 revision as only one member from Japan.
研究兴趣
论文共 1162 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Rheumatology and therapyno. 1 (2024): 223-224
MODERN RHEUMATOLOGYno. 3 (2024): 576-583
JOURNAL OF CLINICAL PHARMACOLOGYno. 4 (2024): 418-427
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2024)
RHEUMATOLOGY (2024)
Rheumatology (Oxford, England)no. 3 (2024): 725-733
Cytokine (2024): 156534-156534
RHEUMATOLOGYno. 2 (2024): 525-533
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn